• Celine Chauleur, Jean Christophe Gris, Sylvie Laporte, Florence Rancon, Marie-Noëlle Varlet, Herve Decousus, Patrick Mismetti, and STRATHEGE Group.
• Gynaecology-Obstetrics Department, EA3065 (Thrombosis Research Group), University Hospital, 42055 Saint-Etienne Cedex 2, Jean Monnet University, France. celine.chauleur@chu-st-etienne.fr
• Thromb. Res. 2010 Aug 1; 126 (2): 88-92.

IntroductionManagement of pregnant women at risk for venous thromboembolism (VTE) remains complex. Guidelines do not definitively fix optimal strategies due to limited trial data. Our objective was to build an easy-to-use tool allowing individualised, risk-adapted prophylaxis.Materials And MethodsA Delphi exercise was conducted to collect 19 French experts' opinions on pregnancy-related VTE.ResultsExperts with an active interest in clinical research and care of VTE and placental vascular complications were selected. The risk score was classified by an anonymous computer vote. A scoring system for VTE risk in pregnant women was developed, each score being associated with a specific treatment: graduated elastic compression stockings, aspirin, prophylactic Low Molecular Weight Heparin (LMWH: variable durations), or adjusted-dose of LMWH through pregnancy and postpartum.ConclusionsOur simple consensual scoring system offers an individual estimation of thrombosis risk during pregnancy together with its related therapeutic strategy, in accordance with most of the new international recommendations. The accuracy of our individual risk score-based therapeutic guidance is currently being prospectively evaluated in a multicenter trial.(c) 2010 Elsevier Ltd. All rights reserved.

20 keywords...

hide…